Trials / Conditions / Irritable Bowel Syndrome With Constipation (IBS-C)

Irritable Bowel Syndrome With Constipation (IBS-C)

10 registered clinical trials studyying Irritable Bowel Syndrome With Constipation (IBS-C) — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs NCT06553547	Ardelyx	Phase 2
Enrolling By Invitation	Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C NCT05905926	Ardelyx	Phase 3
Recruiting	Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than NCT05643534	Ardelyx	Phase 3
Unknown	Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C NCT05240521	Devintec Sagl	N/A
Completed	Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation NCT03471728	Astellas Pharma Inc	—
Completed	A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS NCT02493036	Theriva Biologics, Inc.	Phase 2
Completed	A Study of the Effect of SYN-010 on Subjects With IBS-C NCT02495623	Theriva Biologics, Inc.	Phase 2
Completed	Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irrit NCT02316899	Astellas Pharma Inc	Phase 3
Completed	Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients NCT02078323	Augusta University	N/A
Completed	A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy a NCT01880424	AstraZeneca	Phase 3